Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 1
2014 3
2015 4
2016 5
2017 2
2018 2
2019 3
2020 5
2021 5
2022 17
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Repurposing celecoxib for colorectal cancer targeting via pH-triggered ultra-elastic nanovesicles: Pronounced efficacy through up-regulation of Wnt/β-catenin pathway in DMH-induced tumorigenesis.
El Menshawe SF, Shalaby K, Elkomy MH, Aboud HM, Ahmed YM, Abdelmeged AA, Elkarmalawy M, Abou Alazayem MA, El Sisi AM. El Menshawe SF, et al. Among authors: elkomy mh. Int J Pharm X. 2023 Dec 20;7:100225. doi: 10.1016/j.ijpx.2023.100225. eCollection 2024 Jun. Int J Pharm X. 2023. PMID: 38230407 Free PMC article.
Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats.
Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HAM, Hendawy OM, Abdelgawad MA, Ali HM, Ahmed YM, El-Say KM. Elmowafy M, et al. Among authors: elkomy mh. Drug Deliv Transl Res. 2023 Oct;13(10):2568-2588. doi: 10.1007/s13346-023-01338-3. Epub 2023 Mar 31. Drug Deliv Transl Res. 2023. PMID: 37000409
Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies.
Elhabal SF, Ghaffar SA, Hager R, Elzohairy NA, Khalifa MM, Mohie PM, Gad RA, Omar NN, Elkomy MH, Khasawneh MA, Abdelaal N. Elhabal SF, et al. Among authors: elkomy mh. Int J Pharm X. 2023 Feb 28;5:100174. doi: 10.1016/j.ijpx.2023.100174. eCollection 2023 Dec. Int J Pharm X. 2023. PMID: 36908304 Free PMC article.
55 results